Publication | Closed Access

Gemcitabine Combined with the mTOR Inhibitor Temsirolimus in Patients with Locally Advanced or Metastatic Pancreatic Cancer. A Hellenic Cooperative Oncology Group Phase I/II Study

OncologyPancreatic CancerGastrointestinal OncologyMedicineLocally AdvancedPharmacotherapyMetastatic Pancreatic CancerCancer TreatmentPharmacologyRadiation OncologyMtor Inhibitor TemsirolimusMolecular Oncology